Xtx Topco LTD Black Diamond Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $1.72 Billion
- Q3 2025
A detailed history of Xtx Topco LTD transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 216,195 shares of BDTX stock, worth $910,180. This represents 0.05% of its overall portfolio holdings.
Number of Shares
216,195
Previous 179,234
20.62%
Holding current value
$910,180
Previous $444,000
79.5%
% of portfolio
0.05%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding BDTX
# of Institutions
97Shares Held
41.5MCall Options Held
68.7KPut Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$45.2 Million0.02% of portfolio
-
Vestal Point Capital, LP New York, NY5.55MShares$23.4 Million0.95% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$18.7 Million1.03% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$13.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.19MShares$9.22 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $153M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...